New advances in the fight against the most common form of lung cancer (IMAGE)
Caption
The functional assay dynamic BH3 profiling (DBP), which helps to select the best drug for each patient, was patented in 2015 by the Dana-Farber Cancer Institute (Boston, United States) and its co-inventor is Joan Montero, professor at the UB’s Faculty of Medicine and Health Sciences.
Credit
UNIVERSITY OF BARCELONA
Usage Restrictions
Credit must be given to the creator.
License
CC BY